Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare Properties (NHPAP) Return on Sales (2016 - 2025)

Historic Return on Sales for National Healthcare Properties (NHPAP) over the last 13 years, with Q3 2025 value amounting to 0.15%.

  • National Healthcare Properties' Return on Sales rose 3100.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 4100.0%. This contributed to the annual value of 0.54% for FY2024, which is 3300.0% down from last year.
  • As of Q3 2025, National Healthcare Properties' Return on Sales stood at 0.15%, which was up 3100.0% from 0.24% recorded in Q2 2025.
  • Over the past 5 years, National Healthcare Properties' Return on Sales peaked at 0.02% during Q1 2025, and registered a low of 1.32% during Q2 2024.
  • Over the past 5 years, National Healthcare Properties' median Return on Sales value was 0.21% (recorded in 2022), while the average stood at 0.28%.
  • As far as peak fluctuations go, National Healthcare Properties' Return on Sales crashed by -11200bps in 2024, and later soared by 10700bps in 2025.
  • Quarter analysis of 5 years shows National Healthcare Properties' Return on Sales stood at 0.23% in 2021, then grew by 6bps to 0.22% in 2022, then dropped by -30bps to 0.29% in 2023, then skyrocketed by 32bps to 0.19% in 2024, then grew by 25bps to 0.15% in 2025.
  • Its Return on Sales stands at 0.15% for Q3 2025, versus 0.24% for Q2 2025 and 0.02% for Q1 2025.